Generics Bulletin is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Lists Impurity-Free Valsartan And Other ARB Drugs

Executive Summary

In the wake of impurities being discovered in certain valsartan and other ARB drugs, the FDA has published a list of known nitrosamine-free examples of these medicines as part of ongoing efforts to address the issue.


Related Content

FDA Expresses Concern As Third Nitrosamine Impurity Found In Certain ARB Medicines
FDA Discusses Manufacturing Processes In ARB Medicines Impurities Update
Impure valsartan API prompts recalls in EU


What to read next




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts